Oleacein Prevents High Fat Diet-Induced Adiposity and Ameliorates Some Biochemical Parameters of Insulin Sensitivity in Mice.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
07 08 2019
Historique:
received: 26 06 2019
revised: 02 08 2019
accepted: 05 08 2019
entrez: 10 8 2019
pubmed: 10 8 2019
medline: 23 1 2020
Statut: epublish

Résumé

Oleacein is one of the most abundant polyphenolic compounds of olive oil, which has been shown to play a protective role against several metabolic abnormalities, including dyslipidemia, insulin resistance, and glucose intolerance. Herein, we investigated the effects of oleacein on certain markers of adipogenesis and insulin-resistance in vitro, in 3T3-L1 adipocytes, and in vivo in high-fat diet (HFD)-fed mice. During the differentiation process of 3T3-L1 preadipocytes into adipocytes, oleacein strongly inhibited lipid accumulation, and decreased protein levels of peroxisome proliferator-activated receptor gamma (PPARγ) and fatty acid synthase (FAS), while increasing Adiponectin levels. In vivo, treatment with oleacein of C57BL/6JOlaHsd mice fed with HFD for 5 and 13 weeks prevented the increase in adipocyte size and reduced the inflammatory infiltration of macrophages and lymphocytes in adipose tissue. These effects were accompanied by changes in the expression of adipose tissue-specific regulatory elements such as PPARγ, FAS, sterol regulatory element-binding transcription factor-1 (SREBP-1), and Adiponectin, while the expression of insulin-sensitive muscle/fat glucose transporter Glut-4 was restored in HFD-fed mice treated with oleacein. Collectively, our findings indicate that protection against HFD-induced adiposity by oleacein in mice is mediated by the modulation of regulators of adipogenesis. Protection against HFD-induced obesity is effective in improving peripheral insulin sensitivity.

Identifiants

pubmed: 31394876
pii: nu11081829
doi: 10.3390/nu11081829
pmc: PMC6723526
pii:
doi:

Substances chimiques

Aldehydes 0
Anti-Obesity Agents 0
Biomarkers 0
Glucose Transporter Type 4 0
Phenols 0
Slc2a4 protein, mouse 0
oleacein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

IUBMB Life. 2004 Oct;56(10):595-600
pubmed: 15814457
Nat Med. 2005 Jul;11(7):765-73
pubmed: 15924147
Biotechniques. 2007 Jul;43(1 Suppl):25-30
pubmed: 17936939
Endocr Relat Cancer. 2008 Mar;15(1):325-35
pubmed: 18310298
BMC Biol. 2009 May 21;7:24
pubmed: 19460132
Int J Mol Sci. 2010 Feb 02;11(2):458-79
pubmed: 20386648
Biotechnol J. 2010 Sep;5(9):950-60
pubmed: 20845385
J Hepatol. 2011 May;54(5):984-93
pubmed: 21145829
Sci Rep. 2012;2:251
pubmed: 22355763
Curr Med Chem. 2012;19(23):4006-13
pubmed: 22680639
Mol Endocrinol. 2012 Sep;26(9):1578-89
pubmed: 22745191
Mol Nutr Food Res. 2013 May;57(5):760-71
pubmed: 23450515
Genes Nutr. 2014 Jan;9(1):376
pubmed: 24323842
Evid Based Complement Alternat Med. 2014;2014:971890
pubmed: 24624222
J Transl Med. 2014 Aug 03;12:219
pubmed: 25086598
Mol Nutr Food Res. 2014 Nov;58(11):2166-76
pubmed: 25104077
Phytomedicine. 2015 Dec 15;22(14):1255-61
pubmed: 26655408
Int J Endocrinol. 2015;2015:431453
pubmed: 26798341
Front Endocrinol (Lausanne). 2016 May 27;7:49
pubmed: 27303363
Curr Vasc Pharmacol. 2017;15(1):30-39
pubmed: 27748199
Molecules. 2016 Dec 16;21(12):
pubmed: 27999296
World J Diabetes. 2017 Sep 15;8(9):422-428
pubmed: 28989568
Food Chem. 2018 Apr 15;245:410-414
pubmed: 29287389
Proteomics. 2018 Apr;18(7):e1700260
pubmed: 29466620
Int J Mol Sci. 2018 Feb 28;19(3):null
pubmed: 29495598
Front Endocrinol (Lausanne). 2018 Mar 19;9:116
pubmed: 29615982
J Cell Physiol. 2019 Jun;234(6):8152-8161
pubmed: 30317615
Pharmacol Res. 2019 Apr;142:77-86
pubmed: 30772463
J Clin Invest. 1993 Sep;92(3):1288-95
pubmed: 8376587
J Clin Invest. 1996 Jan 1;97(1):258-62
pubmed: 8550844

Auteurs

Saverio Massimo Lepore (SM)

Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.

Valentina Maggisano (V)

Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.

Stefania Bulotta (S)

Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.

Chiara Mignogna (C)

Interdepartmental Service Center, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.

Biagio Arcidiacono (B)

Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.

Antonio Procopio (A)

Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.

Antonio Brunetti (A)

Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.

Diego Russo (D)

Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy. d.russo@unicz.it.

Marilena Celano (M)

Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH